LAG-3 does not define a specific mode of natural killing in human (Q41027280)

25 September 2017

LAG-3 does not define a specific mode of natural killing in human (English)

1 reference

25 September 2017

Huard B

1

1 reference

PubMed ID

9657262

25 September 2017

Tournier M

series ordinal

2

1 reference

PubMed ID

9657262

25 September 2017

Triebel F

series ordinal

3

1 reference

25 September 2017

1 April 1998

1 reference

25 September 2017

1 reference

25 September 2017

61

1 reference

25 September 2017

109-112

1 reference

25 September 2017

2-3

1 reference

Natural killer cell receptors

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Arousal and inhibition of human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

LAG-3, a novel lymphocyte activation gene closely related to CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Independent modes of natural killing distinguished in mice lacking Lag3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Antibodies against CD14 protect primates from endotoxin-induced shock

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-gamma production .

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900170-3

7 January 2021

10.1016/S0165-2478(97)00170-3

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

9657262